Back to Search
MIKA DERYNCK, M.D.
M.D.
Specialist
NPI: 1477914307Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
GO79889(CA)
Research & Publications (8)
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy.
PMID 17308272·J Clin Oncol·2007
3-trial
A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancer.
PMID 17645829·Clin Genitourin Cancer·2007
3-trial
Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status.
PMID 16896006·J Clin Oncol·2006
3-trial
Activation of stem-cell specific genes by HOXA9 and HOXA10 homeodomain proteins in CD34+ human cord blood cells.
PMID 15849172·Stem Cells·2005
7-preclinical
The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells.
PMID 14604967·Blood·2004
8-other
Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes.
PMID 15501915·Proc Natl Acad Sci U S A·2004
8-other
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
PMID 15289492·J Clin Oncol·2004
3-trial
Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor.
PMID 14617768·Proc Natl Acad Sci U S A·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 27 HILLTOP RD
SAN MATEO, CA 94402 - Phone
- (415) 999-3933
Quick Facts
- NPI
- 1477914307
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile